Phase 0 1 trial
Phase 0
NCT07598578 Jun 2026 → Jan 2030 expected peripheral T-cell lymphoma, not otherwise specified Second Affiliated Hospital of Soochow University
Recruiting
No outcome recorded
Phase 1 10 trials
Phase 1
NCT07635992 Jun 2026 → Dec 2028 expected HIV infectious disease First Affiliated Hospital of Zhejiang University
Not yet recruiting
No outcome recorded
Phase 1
NCT07545967 Apr 2026 → Jul 2027 expected head and neck squamous cell carcinoma West China Hospital
Recruiting
No outcome recorded
Phase 1
NCT05586841 Oct 2022 → Dec 2025 hormone receptor-positive breast cancer Beijing 302 Hospital
Completed
No outcome recorded
Phase 1
NCT05281276 Sep 2022 → Mar 2024 colorectal cancer Taipei Medical University Shuang Ho Hospital
Terminated
No outcome recorded
Phase 1
NCT05338541 May 2022 → Jun 2024 neuroblastoma Yizhuo Zhang
Unknown
No outcome recorded
Phase 1
NCT05083208 Feb 2022 → Jun 2024 peripheral T-cell lymphoma, not otherwise specified Henan Cancer Hospital
Terminated
No outcome recorded
Phase 1
NCT03980691 Dec 2017 → May 2020 HIV infectious disease Guangzhou 8th People's Hospital
Completed
No outcome recorded
Phase 1
NCT02809573 Aug 2016 → Jan 2019 peripheral T-cell lymphoma, not otherwise specified Chipscreen Biosciences, Ltd.
Completed
No outcome recorded
Phase 1
NCT02569489 Dec 2015 breast cancer HUYABIO International, LLC.
Withdrawn
No outcome recorded
Phase 1
NCT02697552 Mar 2014 → Oct 2016 non-Hodgkin lymphoma HUYABIO International, LLC.
Completed
No outcome recorded
Phase 1/2 43 trials
Phase 1/2
NCT07706959 Jul 2026 → Jan 2028 expected peripheral T-cell lymphoma, not otherwise specified Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07601607 May 2026 → May 2028 expected relapsed/refractory diffuse large B-cell lymphoma Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07577986 May 2026 → May 2027 expected HIV infectious disease First Affiliated Hospital of Zhejiang University
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07415980 Apr 2026 → Apr 2028 expected diffuse large B-cell lymphoma Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07320963 Mar 2026 → Mar 2027 expected nasopharyngeal carcinoma Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07493330 Mar 2026 → Dec 2029 expected refractory malignant neoplasm Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07339527 Jan 2026 → Jan 2028 expected mature T-cell and NK-cell non-Hodgkin lymphoma Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07139353 Sep 2025 → Sep 2027 expected peripheral T-cell lymphoma, not otherwise specified Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07133763 Sep 2025 → Sep 2027 expected Epstein-Barr virus-associated lymphoproliferative disorder The Affiliated Hospital of Xuzhou Medical University
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07133776 Sep 2025 → Sep 2027 expected Epstein-Barr virus infection The Affiliated Hospital of Xuzhou Medical University
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07093710 Aug 2025 → Aug 2027 expected peripheral T-cell lymphoma, not otherwise specified Sun Yat-sen University
Recruiting
No outcome recorded
Phase 1/2
NCT06757387 Dec 2024 → Dec 2028 expected peripheral T-cell lymphoma, not otherwise specified Peking University Cancer Hospital & Institute
Not yet recruiting
No outcome recorded
Phase 1/2
NCT06421948 May 2024 → May 2027 expected peripheral T-cell lymphoma, not otherwise specified Yanyan Liu
Recruiting
No outcome recorded
Phase 1/2
NCT06087419 Oct 2023 → Dec 2024 acute lymphoblastic leukemia Institute of Hematology & Blood Diseases Hospital, China
Unknown
No outcome recorded
Phase 1/2
NCT06083701 Sep 2023 → Sep 2024 peripheral T-cell lymphoma, not otherwise specified Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 1/2
NCT06037239 Jul 2023 → Jul 2024 lymphoma Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 1/2
NCT05770882 Apr 2023 → Jan 2025 hepatocellular carcinoma Great Novel Therapeutics Biotech & Medicals Corporation
Terminated
No outcome recorded
Phase 1/2
NCT05675813 Feb 2023 → Jul 2026 overdue peripheral T-cell lymphoma, not otherwise specified Ruijin Hospital
Recruiting
No outcome recorded
Phase 1/2
NCT05682755 Dec 2022 → Dec 2023 overdue acute myeloid leukemia Sichuan University
Recruiting
No outcome recorded
Phase 1/2
NCT05747313 Nov 2022 → Jun 2023 breast cancer , chemotherapy-induced toxicity Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Unknown
No outcome recorded
Phase 1/2
NCT05527275 Oct 2022 → Sep 2024 peripheral T-cell lymphoma, not otherwise specified Sun Yat-sen University
Unknown
No outcome recorded
Phase 1/2
NCT05559008 Sep 2022 → Mar 2024 peripheral T-cell lymphoma, not otherwise specified Ruijin Hospital
Unknown
No outcome recorded
Phase 1/2
NCT05464173 Jul 2022 → Feb 2025 breast cancer Biyun Wang, MD
Unknown
No outcome recorded
Phase 1/2
NCT05186012 Jun 2022 → Sep 2025 non-Hodgkin lymphoma Ascentage Pharma Group Inc.
Unknown
No outcome recorded
Phase 1/2
NCT05370547 May 2022 → Jun 2024 non-Hodgkin lymphoma Chinese PLA General Hospital
Unknown
No outcome recorded
Phase 1/2
NCT05335473 May 2022 → May 2025 Her2-receptor negative breast cancer Henan Cancer Hospital
Unknown
No outcome recorded
Phase 1/2
NCT05320640 Mar 2022 → Apr 2024 non-Hodgkin lymphoma Chinese PLA General Hospital
Unknown
No outcome recorded
Phase 1/2
NCT05270200 Feb 2022 → Dec 2027 expected acute myeloid leukemia Zhujiang Hospital
Recruiting
No outcome recorded
Phase 1/2
NCT05075681 Nov 2021 → Jun 2024 disease related to hematopoietic stem cell transplant Chinese PLA General Hospital
Unknown
No outcome recorded
Phase 1/2
NCT03838354 Jun 2021 → Sep 2022 thrombocytopenia Shandong University
Completed
No outcome recorded
Phase 1/2
NCT05140616 May 2021 → May 2024 —
The First Affiliated Hospital of Soochow University
Unknown
No outcome recorded
Phase 1/2
NCT04651127 Nov 2020 → Jan 2023 cervical cancer Sun Yat-sen University
Terminated
No outcome recorded
Phase 1/2
NCT04553393 Sep 2020 → Sep 2021 aggressive B-cell non-Hodgkin lymphoma Chinese PLA General Hospital
Unknown
No outcome recorded
Phase 1/2
NCT04337606 Apr 2020 → Apr 2024 non-Hodgkin lymphoma Chinese PLA General Hospital
Unknown
No outcome recorded
Phase 1/2
NCT04025450 Jul 2019 → Jul 2029 expected plasma cell myeloma The First Affiliated Hospital of Soochow University
Recruiting
No outcome recorded
Phase 1/2
NCT03974243 Jul 2019 → Dec 2021 non-Hodgkin lymphoma Chipscreen Biosciences, Ltd.
Completed
No outcome recorded
Phase 1/2
NCT03820596 Mar 2019 → May 2020 —
Huiqiang Huang
Completed
No outcome recorded
Phase 1/2
NCT03453255 Jan 2018 → Dec 2019 —
Chinese PLA General Hospital
Unknown
No outcome recorded
Phase 1/2
NCT03031262 Feb 2017 → Apr 2025 overdue acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Active not recruiting
No outcome recorded
Phase 1/2
NCT02718066 Aug 2016 → Sep 2023 melanoma , non-small cell lung carcinoma , renal cell carcinoma HUYABIO International, LLC.
Completed
No outcome recorded
Phase 1/2
NCT02886559 Jun 2016 → Jun 2018 acute myeloid leukemia Chinese PLA General Hospital
Unknown
No outcome recorded
Phase 1/2
NCT02987244 Mar 2016 → Mar 2020 T-cell non-Hodgkin lymphoma Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 1/2
NCT02513901 Aug 2015 → Feb 2016 —
Tang-Du Hospital
Completed
No outcome recorded
Show 33 more trials Phase 2 159 trials
Phase 2
NCT07616336 Jul 2026 → Mar 2027 expected myelodysplastic syndrome Zhongshan Hospital (Xiamen), Fudan University
Not yet recruiting
No outcome recorded
Phase 2
NCT07643636 Jun 2026 → Jun 2028 expected acute myeloid leukemia Dongguan People's Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07507318 Jun 2026 → Jun 2029 expected diffuse large B-cell lymphoma Rong Tao
Recruiting
No outcome recorded
Phase 2
NCT07412262 May 2026 → Mar 2028 expected non-small cell lung carcinoma Guangdong Association of Clinical Trials
Not yet recruiting
No outcome recorded
Phase 2
NCT07602322 May 2026 → May 2028 expected large B-cell lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07552324 May 2026 → May 2027 expected T-cell/histiocyte rich large B cell lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07493148 Apr 2026 → Dec 2029 expected diffuse large B-cell lymphoma Ou Bai, MD/PHD
Recruiting
No outcome recorded
Phase 2
NCT07651475 Mar 2026 overdue acute myeloid leukemia Liping Dou
Active not recruiting
No outcome recorded
Phase 2
NCT07518602 Mar 2026 → Mar 2028 expected neuroendocrine carcinoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT07570849 Mar 2026 → Jun 2027 expected intrahepatic cholangiocarcinoma Shanghai Zhongshan Hospital
Recruiting
No outcome recorded
Show all 159 trials opens the full record — a long page Phase 2/3 5 trials
Phase 2/3
NCT05253066 Feb → Jul 2022 breast neoplasm Shengjing Hospital
Unknown
No outcome recorded
Phase 2/3
NCT02902185 Nov 2016 → Aug 2018 —
Tang-Du Hospital
Unknown
No outcome recorded
Phase 2/3
NCT03564704 Feb 2016 → May 2021 T-cell leukemia , adult acute lymphoblastic leukemia , lymphoblastic lymphoma Nanfang Hospital, Southern Medical University
Unknown
No outcome recorded
Phase 2/3
NCT03553238 Feb 2016 → May 2020 T lymphoblastic leukemia/lymphoma , T-cell leukemia , acute leukemia Nanfang Hospital, Southern Medical University
Unknown
No outcome recorded
Phase 2/3
NCT03564470 Feb 2016 → Aug 2023 B-cell acute lymphoblastic leukemia Nanfang Hospital, Southern Medical University
Unknown
No outcome recorded
Phase 3 15 trials
Phase 3
NCT07639879 Jul 2026 → Jul 2029 expected mature T-cell and NK-cell non-Hodgkin lymphoma Tarapeutics Science Inc.
Not yet recruiting
No outcome recorded
Phase 3
NCT07493109 May 2026 → Sep 2029 expected diffuse large B-cell lymphoma Ou Bai, MD/PHD
Recruiting
No outcome recorded
Phase 3
NCT06947967 Aug 2025 → Dec 2032 expected peripheral T-cell lymphoma, not otherwise specified Chipscreen Biosciences, Ltd.
Recruiting
No outcome recorded
Phase 3
NCT06776952 Apr 2025 → Jan 2028 expected peripheral T-cell lymphoma, not otherwise specified Evopoint Biosciences Inc.
Recruiting
No outcome recorded
Phase 3
NCT06497985 Dec 2024 → May 2028 expected colorectal cancer Chipscreen Biosciences, Ltd.
Recruiting
No outcome recorded
Phase 3
NCT06255795 Feb 2024 → Dec 2026 expected mature T-cell and NK-cell non-Hodgkin lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 3
NCT06122389 Feb 2024 → May 2026 overdue peripheral T-cell lymphoma, not otherwise specified Jiangsu HengRui Medicine Co., Ltd.
Recruiting
No outcome recorded
Phase 3
NCT05768503 Mar 2023 → Jan 2026 overdue colorectal cancer Sun Yat-sen University
Recruiting
No outcome recorded
Phase 3
NCT05678933 Jan 2023 → Dec 2027 expected peripheral T-cell lymphoma, not otherwise specified Tianjin Medical University Cancer Institute and Hospital
Enrolling by invitation
No outcome recorded
Phase 3
NCT05466318 Jul 2022 → Dec 2025 T-cell non-Hodgkin lymphoma , diffuse large B-cell lymphoma Sichuan University
Unknown
No outcome recorded
Phase 3
NCT05075460 Oct 2021 → May 2024 T-cell non-Hodgkin lymphoma Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 3
NCT04674683 Aug 2021 → Jul 2026 overdue metastatic malignant neoplasm in the brain , metastatic melanoma HUYABIO International, LLC.
Active not recruiting
No outcome recorded
Phase 3
NCT04231448 May 2020 → Jan 2023 diffuse large B-cell lymphoma Chipscreen Biosciences, Ltd.
Completed
No outcome recorded
Phase 3
NCT03023358 Feb 2017 → Mar 2019 peripheral T-cell lymphoma, not otherwise specified Nanfang Hospital, Southern Medical University
Unknown
No outcome recorded
Phase 3
NCT02482753 Jul 2015 → Mar 2018 breast cancer Chipscreen Biosciences, Ltd.
Completed
No outcome recorded
Show 5 more trials Phase 4 4 trials
Phase 4
NCT05191914 Feb → Jul 2022 breast cancer Liaoning Cancer Hospital & Institute
Unknown
No outcome recorded
Phase 4
NCT04040491 Sep 2019 → Dec 2020 peripheral T-cell lymphoma, not otherwise specified Mingzhi Zhang
Unknown
No outcome recorded
Phase 4
NCT04038411 Apr 2019 → Apr 2021 mature T-cell and NK-cell non-Hodgkin lymphoma Mingzhi Zhang
Unknown
No outcome recorded
Phase 4
NCT04490590 Oct 2016 → Oct 2020 mature T-cell and NK-cell non-Hodgkin lymphoma Mingzhi Zhang
Unknown
No outcome recorded
Phase not applicable 17 trials
— NCT07521124 Jun 2026 → Jun 2029 expected acute myeloid leukemia Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not yet recruiting
No outcome recorded
— NCT07542912 Jun 2026 → Jun 2029 expected —
Sun Yat-sen University
Not yet recruiting
No outcome recorded
— NCT07072221 Nov 2024 → Aug 2029 expected peripheral T-cell lymphoma, not otherwise specified The First Affiliated Hospital of Soochow University
Recruiting
No outcome recorded
— NCT07074457 Nov 2024 → Aug 2028 expected peripheral T-cell lymphoma, not otherwise specified The First Affiliated Hospital of Soochow University
Recruiting
No outcome recorded
— NCT06386302 Aug 2024 → Dec 2027 expected acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Recruiting
No outcome recorded
— NCT06066905 Oct 2023 → Dec 2026 expected acute myeloid leukemia Guangdong Provincial People's Hospital
Recruiting
No outcome recorded
— NCT06211881 Oct 2023 → Sep 2025 mature T-cell and NK-cell non-Hodgkin lymphoma The First Affiliated Hospital with Nanjing Medical University
Unknown
No outcome recorded
— NCT05890287 May 2023 → May 2026 overdue hormone receptor-positive breast cancer Tianjin Medical University Cancer Institute and Hospital
Recruiting
No outcome recorded
— NCT05784987 Apr 2023 → Jan 2024 diffuse large B-cell lymphoma The First Affiliated Hospital with Nanjing Medical University
Unknown
No outcome recorded
— NCT05896813 Mar 2023 → Jan 2025 peripheral T-cell lymphoma, not otherwise specified The First Affiliated Hospital with Nanjing Medical University
Unknown
No outcome recorded
— NCT05478473 Oct 2022 → Aug 2023 melanoma Peking University Cancer Hospital & Institute
Unknown
No outcome recorded
— NCT05047848 Aug 2021 → Jun 2022 female breast carcinoma Liaoning Cancer Hospital & Institute
Unknown
No outcome recorded
— NCT05137522 Jul 2021 → Jul 2023 hemophagocytic syndrome Beijing Friendship Hospital
Unknown
No outcome recorded
— NCT04582955 Oct 2020 → Dec 2022 triple-negative breast carcinoma Tianjin Medical University Cancer Institute and Hospital
Unknown
No outcome recorded
— NCT04319601 Mar 2020 → Mar 2022 angioimmunoblastic T-cell lymphoma , chemotherapy-induced toxicity Zhejiang Cancer Hospital
Unknown
No outcome recorded
— NCT03268889 Jun 2017 → Jun 2020 peripheral T-cell lymphoma, not otherwise specified The First Affiliated Hospital of Soochow University
Unknown
No outcome recorded
— NCT04511351 Aug 2014 → Dec 2020 lymphoma Chinese Academy of Medical Sciences
Unknown
No outcome recorded
Show 7 more trials